Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MYOLYN is a medical technology company based in Gainesville, Florida, that specializes in Functional Electrical Stimulation (FES) devices for individuals with neurological impairments. Founded in 2013 as a spin-out from the University of Florida, the company focuses on making advanced neuro-rehabilitation technology affordable and accessible for both clinical and home use. Its flagship product line, the MyoCycle, is an FDA-cleared stationary bike that uses patented algorithms to stimulate paralyzed or weakened muscles, enabling therapeutic exercise for patients with spinal cord injuries, stroke, and multiple sclerosis. MYOLYN has established significant partnerships, including an exclusive distribution agreement with Lifeward (formerly ReWalk Robotics), to expand its reach in the rehabilitation market. The company continues to innovate with new products like the MyoRow, an FES-enabled rowing system currently in development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MYOLYN.